Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Entos Pharmaceuticals Inc.

Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics
From Entos Pharmaceuticals Inc.
Via Business Wire
Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized Lipodystrophy Program
From Entos Pharmaceuticals Inc.
Via Business Wire
Entos Pharmaceuticals Announces First Participant Dosed in Clinical Trial for COVID-19 Vaccine Booster
From Entos Pharmaceuticals Inc.
Via Business Wire
New Article Published in Cell Describes the Safe and Effective Delivery of DNA and RNA Using Proteolipid Vehicles
From Entos Pharmaceuticals Inc.
Via Business Wire
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster
From Entos Pharmaceuticals Inc.
Via Business Wire
Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases
From Entos Pharmaceuticals Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.